Court, Explained
U.S. Federal District Courts
Back to docket
N.D. Cal.Procedural orderFiled Mar. 14, 2022

LHC Group, Inc. v. Bayer Corp.

Judge
Haywood Gilliam
Docket
4:21-cv-03877
Court
U.S. District Court · Northern District of California
Pages
5
Civil ProcedureErisa
In one sentence

In LHC Group v. Bayer, Judge Gilliam granted remand because ERISA did not completely preempt the state-law claims.

Who this affects

LHC Group, Inc., the Bayer defendants, and the plan members whose claims LHC Group asserted. The case was returned to Alameda County Superior Court, and the defendants’ pending motion to dismiss was denied without prejudice as moot.

What happened

LHC Group, Inc. v. Bayer Corp. involved state-law claims that LHC Group brought on behalf of healthcare-plan members against Bayer entities over an allegedly defective birth control product. The defendants moved the case from Alameda County Superior Court to federal court, arguing that the claims were completely preempted by the Employee Retirement Income Security Act, or ERISA.

The court held that the claims did not meet either part of the test for complete ERISA preemption. The claims were not seeking benefits under the ERISA plan, and they were based on duties—such as duties related to negligence and defective products—that existed independently of the plan.

Judge Haywood S. Gilliam, Jr. granted LHC Group’s motion to remand the case to Alameda County Superior Court. The court also denied the defendants’ pending motion to dismiss without prejudice as moot and directed the clerk to close the federal case.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
LHC Group, Inc. v. Bayer Corp. · No. 4:21-cv-03877
Judge
Haywood Gilliam
Date
Mar. 14, 2022

Background

LHC Group, Inc. administered a healthcare benefit plan governed by the Employee Retirement Income Security Act of 1974, or ERISA. Under the plan, LHC Group reimbursed members for medical-treatment expenses. The members also assigned LHC Group their rights to bring personal-injury claims against third parties.

LHC Group filed state-law claims on behalf of plan members against Bayer Corp., Bayer HealthCare LLC, Bayer Essure Inc., and Bayer HealthCare Pharmaceuticals, Inc. The claims concerned the manufacture and sale of an allegedly defective birth control product. After LHC Group filed the case in Alameda County Superior Court, the defendants removed it to federal court, arguing that ERISA completely preempted the claims. LHC Group moved to remand, meaning it asked the federal court to return the case to state court.

Complete Preemption Analysis

Federal courts generally cannot hear state-law claims merely because a defendant argues that federal law preempts them. An exception exists for complete preemption, which can convert certain state-law claims into federal claims for jurisdictional purposes. The court applied the two-part test from Aetna Health Inc. v. Davila: complete preemption requires that (1) the plaintiff could have brought the claim under ERISA’s civil-enforcement provision, Section 502(a)(1)(B), and (2) no independent legal duty is implicated by the defendant’s conduct.

For the first part, the defendants argued that LHC Group sought to enforce rights under the ERISA plan because the plan contained a subrogation provision assigning LHC Group the right to sue on behalf of plan members. The court rejected that argument. It explained that the relevant question was whether these particular claims could have been brought under Section 502(a)(1)(B) to obtain benefits or enforce rights under the plan. LHC Group’s claims were instead state-law claims assigned to it to enforce on behalf of plan members, not claims seeking benefits under the plan. The defendants therefore did not satisfy the first part of the test.

The court also held that the claims failed the second part of the test. It rejected the defendants’ argument that the claims were not independent because they could not exist without the ERISA plan. The relevant question was the source of the legal duty, not the claim’s relationship to a healthcare plan. The court found that LHC Group’s claims for negligence, strict products liability, concealment, contract, and unjust enrichment were based on duties independent of the ERISA plan.

Disposition

Because the claims met neither part of the complete-preemption test, the court concluded that ERISA did not completely preempt them and that the federal court lacked subject-matter jurisdiction. The court granted LHC Group’s motion to remand the case to Alameda County Superior Court. It stated that any conflict-preemption defense could be raised in state court, but that defense could not establish federal-question jurisdiction.

The court denied the defendants’ pending motion to dismiss without prejudice as moot. The clerk was directed to remand the case to state court and close the federal file.

The authoritative version

Read the full 5-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.